Home Biosimilar Antibodies Others Others Anti-CLEC4C (BIIB059)
For research use only. Not for use in humans.

Anti-CLEC4C (BIIB059)

Synonyms: Litifilimab

Anti-CLEC4C (BIIB059) is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). It can be used for cutaneous lupus erythematosus (CLE) study. MW :146.34 KD.

Anti-CLEC4C (BIIB059)

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet

Mechanism of Action

Description
Anti-CLEC4C (BIIB059) is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). It can be used for cutaneous lupus erythematosus (CLE) study. MW :146.34 KD.
References

Product Details

CAS No. 2407378-48-5
Molecular Weight 146.34
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.